Durvalumab vs Warfarin

Durvalumab vs Warfarin: Overview

This comparison examines the pharmacological differences between Durvalumab and Warfarin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Warfarin: Inhibits vitamin K epoxide reductase complex.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Warfarin — 20-60 hours.

Chemical Properties

Molecular Formula: Warfarin — C19H16O4.

Molecular Weight: Warfarin — 308.3280 g/mol.

Type: Durvalumab — Antibody; Warfarin — Small molecule.